Cargando…
The simultaneous effects of pharmaceutical policies from payers’ and patients’ perspectives: Italy as a case study
OBJECTIVES: This paper aims at covering a literature gap on the effects of copayments, prescription quotas and therapeutic reference pricing on public and private expenditures and volumes (1) When these policies are implemented in different areas at different times, (2) estimating their impact in th...
Autores principales: | Armeni, Patrizio, Jommi, Claudio, Otto, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047928/ https://www.ncbi.nlm.nih.gov/pubmed/26507643 http://dx.doi.org/10.1007/s10198-015-0739-0 |
Ejemplares similares
-
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
por: Tarantola, Alice, et al.
Publicado: (2023) -
Il futuro dei Fondi per Farmaci Innovativi: risultati di uno studio basato su Delphi panel
por: Jommi, Claudio, et al.
Publicado: (2021) -
Pharmaceutical Technology Assessment: Perspectives from Payers
por: Leung, Musetta Y., et al.
Publicado: (2012) -
The assessment of new drugs for asthma and COPD: a Delphi study examining the perspectives of Italian payers and clinicians
por: Sommariva, Silvia, et al.
Publicado: (2016) -
The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy
por: Otto, Monica Hildegard, et al.
Publicado: (2018)